MedPath

LAZCLUZE 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

LAZCLUZE 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Pending
Register Number

1241886005

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jan 29, 2025

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1241886005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

LAZERTINIBActive
Quantity: 240 mg
Name: LAZERTINIB

ATC CLASSIFICATION (3)

L01E
L01EB
L01EB09

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.